Chapter

Current Topics in Complement II

Volume 632 of the series Advances in Experimental Medicine and Biology pp 68-76

Date:

Interaction Between the Coagulation and Complement System

  • Umme AmaraAffiliated withDepartment of Traumatology, Hand-, Plastic-, and Reconstructive Surgery, University Hospital of Ulm Email author 
  • , Daniel RittirschAffiliated withDepartment of Traumatology, Hand-, Plastic-, and Reconstructive Surgery, University Hospital of Ulm
  • , Michael FlierlAffiliated withDepartment of Traumatology, Hand-, Plastic-, and Reconstructive Surgery, University Hospital of Ulm
  • , Uwe BrucknerAffiliated withDivision of Experimental Surgery, University Hospital of Ulm Email author 
  • , Andreas KlosAffiliated withDepartment of Medical Microbiology, Medical School Hannover Email author 
  • , Florian GebhardAffiliated withDepartment of Traumatology, Hand-, Plastic-, and Reconstructive Surgery, University Hospital of Ulm
  • , John D. LambrisAffiliated withDepartment of Pathology, University of Pennsylvania Email author 
  • , Markus Huber-LangAffiliated withDepartment of Traumatology, Hand-, Plastic-, and Reconstructive Surgery, University Hospital of Ulm

* Final gross prices may vary according to local VAT.

Get Access

Abstract

The complement system as a main column of innate immunity and the coagulation system as a main column in hemostasis undergo massive activation early after injury. Interactions between the two cascades have often been proposed but the precise molecular pathways of this interplay are still in the dark. To elucidate the mechanisms involved, the effects of various coagulation factors on complement activation and generation of anaphylatoxins were investigated and summarized in the light of the latest literature. Own in vitro findings suggest, that the coagulation factors FXa, FXIa and plasmin may cleave both C5 and C3, and robustly generate C5a and C3a (as detected by immunoblotting and ELISA). The produced anaphylatoxins were found to be biologically active as shown by a dose-dependent chemotactic response of neutrophils and HMC-1 cells, respectively. Thrombin did not only cleave C5 (Huber-Lang et al. 2006) but also in vitro-generated C3a when incubated with native C3. The plasmin-induced cleavage activity could be dose-dependently blocked by the serine protease inhibitor aprotinin and leupeptine. Theese findings suggest, that various serine proteases belonging to the coagulation system are able to activate the complement cascade independently of the established pathways. Moreover, functional C5a and C3a are generated, both of which are known to be crucially involved in the inflammatory response.